Next Article in Journal
Substantially Modified Ratios of Effector to Regulatory T Cells During Chemotherapy in Ovarian Cancer Patients Return to Pre-Treatment Levels at Completion: Implications for Immunotherapy
Previous Article in Journal
Potentiality and Boundaries of Use of Sorafenib in Patients with Hepatocellular Carcinoma: Awaiting the Results of Ongoing Clinical Trials
Previous Article in Special Issue
Postoperative Radiation Therapy for Non-Small Cell Lung Cancer and Thymic Malignancies
Cancers 2012, 4(2), 566-580; doi:10.3390/cancers4020566

Notes on Article Versions

NoteDate
article html file updated23 January 2013 19:56 CET
article html file updated26 January 2013 11:14 CET
article html file updated29 January 2013 04:39 CET
article xml file uploaded1 February 2013 09:36 CET
article html file updated1 February 2013 09:36 CET
article html file updated6 February 2013 08:17 CET
article html file updated7 February 2013 02:48 CET
article html file updated7 February 2013 12:55 CET
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert